Shkreli Gets Seven-Year Prison Sentence for Stock Fraud Conviction
Former pharmaceutical executive Martin Shkreli has been sentenced to seven years in prison after his conviction on three securities fraud counts.
March 09, 2018 at 02:19 PM
6 minute read
Benjamin Brafman, counsel to former pharmaceutical executive Martin Shkreli, speaks with reporters at the Eastern District courthouse in Brooklyn on March 9, 2018. Photo: Andrew Denney/ALM
Former pharmaceutical executive Martin Shkreli, who was propelled to fame a few years ago for a massive price increase on a lifesaving drug for people with HIV and AIDS, was sentenced on Friday to seven years in prison for three securities fraud counts.
U.S. District Judge Kiyo Matsumoto of the Eastern District of New York handed down the sentence after a three-hour hearing in which lawyers, the judge and even Shkreli himself painted a complex picture of the disgraced executive and online provocateur who at one point earned the monikers “Pharma Bro” and “most hated man in America.”
Shkreli, who appeared in the courtroom in blue jail scrubs, had provided an emotional statement prior to the sentencing expressing remorse for his offenses and contending that he has worked to better himself during his months at the Metropolitan Detention Center in Brooklyn, but was expressionless as the judge delivered his sentence.
“There is no conspiracy to take down Martin Shkreli—I took down Martin Shkreli with my disgraceful and shameful acts,” Shkreli said during his statement, choking back tears.
But Matsumoto said that Shkreli's conduct translated to an “egregious multitude of lies and abuse of trust” and that her sentence should “protect the public” from Shkreli, promote respect for the law and deter him from re-offending.
Shkreli was convicted in August following a five-week trial of two counts of securities fraud and a related securities fraud for a scheme in which he defrauded investors to two hedge funds he created, MSMB Capital and MSMB Healthcare.
Shkreli later paid back the investors with assets from Retrophin, a pharmaceutical company that he also founded. He conspired with Retrophin's attorney, former Katten Muchin Rosenman partner Evan Greebel, who later became Shkreli's co-defendant, and other co-conspirators to manipulate the price and volume of shares in Retrophin.
In December, Greebel, who was also tried before Matsumoto, was convicted of conspiracy to commit wire fraud and conspiracy to commit securities fraud for his role in the scheme.
Matsumoto sentenced Shkreli to seven years in prison on each of the fraud counts and five years on the conspiracy counts, with the sentences to run concurrently.
The jury acquitted Shkreli of five counts, but he was delivered a series of setbacks in post-conviction proceedings in the months leading up to his sentencing.
In September, Matsumoto revoked Shkreli's bail after he posted a $5,000 bounty for a lock of hair from the head of Hillary Clinton, who was on a book tour at the time, on his Facebook page to some 90,000 followers. Shkreli has been incarcerated ever since.
Matsumoto granted time served for the roughly six months he has spent at the Metropolitan Detention Center in Brooklyn.
On Feb. 26, Matsumoto found that the loss to investors in Shkreli's fraud scheme for his convicted conduct was valued at $10.4 million, rejecting Shkreli's argument that there was no loss and which had a bearing on the calculation of his sentence.
The following week, Matsumoto granted the government's motion to seize $7.36 million of Shkreli's assets, which includes $5 million from a brokerage account and a one-of-a-kind Wu-Tang Clan album that Shkreli said he bought for $2 million.
Shkreli's sentence falls far below the maximum of 33 years suggested by federal sentencing guidelines, but falls in between Shkreli's argument that he should serve up to 18 months with community service and mandated therapy and the government's position that he should serve no less than 15 years.
Matsumoto's sentence also appeared to strike a balance between the competing portrayals presented by federal prosecutors and Shkreli's defense team.
In this courtroom sketch, Martin Shkreli, left, listens as his lawyer Ben Brafman, second from left, speaks to Judge Kiyo Matsumoto, top right, in federal court on March 9, 2018, in New York. Photo: Elizabeth Williams via AP
In his remarks before the judge, Benjamin Brafman, Shkreli's lead counsel, reiterated a theme he has emphasized throughout the trial: that Shkreli is a misunderstood and slightly off-beat wunderkind who sometimes shoots off his mouth in public statements, but who never intended to defraud his investors, noting that the investors who were affected by the scheme all ended up making money.
“There were times when I wanted to hug him and hold him,” Brafman said. “There were times I wanted to punch him in the face.”
Brafman also worked to cut a more sympathetic figure of his client during his roughly hour-long argument, discussing his charitable works and saying Shkreli's been teaching math to fellow MDC inmates and helping them get books,
But Assistant U.S. Attorney Jacquelyn Kasulis of the Eastern District, who presented arguments for the government, cast Shkreli as a self-serving fraudster who was interested in getting rich, saying that he was convicted of running four different fraud schemes over a five-year period.
“He wants everyone to believe he is a genuine whiz kid, a self-taught biotech wonder, the richest man in New York City,” Kasulis said. “Without that image he is nothing.”
Matsumoto said that Shkreli's “self-cultivated” public persona did not have a bearing on her sentence, nor did his price hike on Daraprim, a potentially life-saving drug for people who suffer from HIV and AIDS, from $13.50 per pill to $750, which initially propelled him to fame.
Matsumoto also gave Shkreli a downward departure in her sentencing calculation for his charitable donations, which included a $1 million donation to Hunter College High School and support for an LGBT advocacy group.
But the judge said that Shkreli repeatedly lied to MSMB investors and strung them along for years about the performance of their investments. She also read Shkreli's statements about an investor who wanted out of the scheme, in which Shkreli said he threatened the investor and his family.
Kasulis was joined on the prosecution team by Assistant U.S. Attorneys Alixandra Smith and Girish Srinivasan.
“For years, Shkreli told lie after lie in order to steal his investors' money, manipulate the
stock market and enrich himself,” said interim U.S. Attorney Richard Donoghue in a news release. “He will now pay the price for repeatedly violating the trust placed in him by his investors, his employees and the public.”
In a brief news conference outside the Eastern District courthouse in Brooklyn, Brafman said he was disappointed with the sentence.
“The government didn't get what they wanted,” Brafman said. “We didn't get what we wanted, either.”
Shkreli's defense team also included Brafman & Associates attorneys Marc Agnifilo, Andrea Zellan, Jacob Kaplan and Teny Geragos.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllUS Judge Rejects Morgan Stanley Reconsideration Bid in Deferred Compensation Litigation
US Bankruptcy Filings Rise 16.2% as Interest Rates, Inflation, and End of COVID Relief Hit Hard
3 minute readTrump Win Ignites Global Legal Market: Lawyers Prepare for High Demand & Uncertainty
Judge Orders Rudy Giuliani to Court Amid Allegations He's Hiding Assets Under Receivership
Trending Stories
- 1Infant Formula Judge Sanctions Kirkland's Jim Hurst: 'Overtly Crossed the Lines'
- 2Trump's Return to the White House: The Legal Industry Reacts
- 3Election 2024: Nationwide Judicial Races and Ballot Measures to Watch
- 4Climate Disputes, International Arbitration, and State Court Limitations for Global Issues
- 5Judicial Face-Off: Navigating the Ethical and Efficient Use of AI in Legal Practice [CLE Pending]
- 6How Much Does the Frequency of Retirement Withdrawals Matter?
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250